Treatment With (Es)ketamine in Catatonia
Recent evidence suggests that NMDA receptor antagonists, such as ketamine, may offer benefit in catatonia. This systematic review was conducted to evaluate the efficacy and safety of ketamine and esketamine for catatonia.
Authors
- Metten Somers (ORCID: https://orcid.org/0000-0002-9381-5596)
- Annemiek Dols (ORCID: https://orcid.org/0000-0003-1964-0318)
- Albert Batalla (ORCID: https://orcid.org/0000-0002-5010-5121)
- Jan W. Schoones (ORCID: https://orcid.org/0000-0003-1120-4781)
- Arjen J. C. Slooter (ORCID: https://orcid.org/0000-0003-0804-8378)
- Sebastiaan O Verboeket
- Pim B. van der Meer (ORCID: https://orcid.org/0000-0003-3700-8906)
- Martijn S. van Noorden (ORCID: https://orcid.org/0000-0003-4156-4112)
Institutions
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- The Journal of Clinical Psychiatry
- Published
- 2025-10-13
- DOI
- https://doi.org/10.4088/jcp.25br15940
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00